Evidence map›Paper›PMID 42267182›Full record

ReviewFrontiers in cell and developmental biology2026

Decoding cardiac homeostasis and injury: the evolving landscape of spatial transcriptomics.

Anis Hanna

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Anis HannaThe Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, New York City, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The heart is a structurally complex organ where function is intimately tied to the precise spatial organization of diverse cell types. While single-cell RNA sequencing (scRNA-seq) has revolutionized cardiovascular research by providing a high-resolution "parts list" of the heart, the requisite tissue dissociation destroys the critical spatial context of intercellular communication and microenvironmental niches. Spatial transcriptomics (ST) has emerged as a transformative technology that bridges this gap, enabling the mapping of gene expression back to its histological coordinates. This review discusses the rapidly evolving landscape of spatial technologies, categorizing them into sequencing-based methods (e.g., Visium, Stereo-seq) which offer transcriptome-wide discovery, and imaging-based methods (e.g., MERFISH, Xenium, CosMx) which provide subcellular resolution with high sensitivity. We highlight recent applications of these tools in uncovering the spatial architecture of the heart at homeostasis and following injury. Furthermore, we explore the next frontier of spatial multi-omics, including simultaneous profiling of the proteome via sequential immunofluorescence (seq-IF) and expansion proteomics (iPEX), as well as chromatin accessibility. We conclude by discussing the computational challenges and future perspectives of integrating these multi-modal datasets to construct comprehensive atlases of the healthy and injured heart.

Indexed as

heart failuremulti-omicsmyocardial infarctionsingle cellspatial transcriptomics

Identifiers

PMID42267182
PMCPMC13243245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.